Skip to main content
Top
Published in: European Journal of Nuclear Medicine and Molecular Imaging 2/2009

01-02-2009 | Occasional Survey

Myocardial perfusion scintigraphy in Europe 2005

A survey of the European Council on Nuclear Cardiology

Authors: S. Richard Underwood, Susanna Wiener

Published in: European Journal of Nuclear Medicine and Molecular Imaging | Issue 2/2009

Login to get access

Abstract

Purpose

We have conducted a survey of myocardial perfusion scintigraphy (MPS) in 2005 in Europe with the intention of initiating a regular series of surveys to track usage of the technique.

Methods

Information was obtained from 234 centres in 18 counties. The returning centres served 27% of the population of their countries, and estimates of the numbers of MPS per million of population (pmp) were made assuming that the population not reported either performed no studies (lower estimate) or the same number pmp as the reporting centres (upper estimate).

Results

Estimates of MPS for the countries surveyed ranged from a lower limit of 373 pmp to an upper limit of 1,388 pmp. There were marked variations between countries with higher numbers (lower limit of estimate above the mid range of all countries combined) in Austria, Greece, Hungary, the Netherlands, Sweden and Slovenia, and lower numbers (upper limit of estimate below the mid range of all countries) in Finland, Germany and Poland. The ratio of MPS to coronary angiography to revascularisation procedures was 0.6 to 1.5 to 1. The median number of studies per centre was 496, with 32% of centres performing fewer than 250 studies in the year. The median waiting time for routine studies was 21 days and for urgent studies 3.4 days. Fifty-three percent of studies used pharmacological stress, with roughly equal numbers of adenosine and dipyridamole. Eighty-two percent of studies used 99mTc-based tracers. Tomographic acquisition was almost universal with 65% of studies being ECG-gated and 20% attenuation-corrected. Eighteen percent of studies were reported from hard copy alone, and 60% of studies were reported without viewing the rotating planar data.

Conclusion

We conclude that relatively low numbers of MPS studies are being performed in the surveyed centres, particularly when compared with coronary angiography and revascularisation. The use of 99mTc-based tracers is high, but ECG-gated studies are less common. Some reporting practices are not ideal. These data will serve as a valuable baseline for future surveys, which are likely to be more complete.
Appendix
Available only for authorised users
Literature
1.
go back to reference Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint J, Harbinson M, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med 2004;31:261–91.CrossRef Underwood SR, Anagnostopoulos C, Cerqueira M, Ell PJ, Flint J, Harbinson M, et al. Myocardial perfusion scintigraphy: the evidence. Eur J Nucl Med 2004;31:261–91.CrossRef
2.
go back to reference National Institute of Health and Clinical Excellence. Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Technology appraisal 73, November 2003. http://www.nice.nhs.uk/ta073 accessed 19/02/2008. National Institute of Health and Clinical Excellence. Myocardial perfusion scintigraphy for the diagnosis and management of angina and myocardial infarction. Technology appraisal 73, November 2003. http://​www.​nice.​nhs.​uk/​ta073 accessed 19/02/2008.
3.
go back to reference Pennell DJ, Prvulovich EM, Tweddel A, Caplin J. Nuclear cardiology in the UK 1994: activity relative to Europe, USA, and British Cardiac Society targets. Heart 1998;80:296–8.PubMed Pennell DJ, Prvulovich EM, Tweddel A, Caplin J. Nuclear cardiology in the UK 1994: activity relative to Europe, USA, and British Cardiac Society targets. Heart 1998;80:296–8.PubMed
4.
go back to reference IMV Medical Information Division. 2005 Nuclear Medicine Census Market Summary Report (released July 2006). IMV Medical Information Division. 2005 Nuclear Medicine Census Market Summary Report (released July 2006).
5.
go back to reference Underwood SR, Gibson C, Tweddel A, et al. A survey of nuclear cardiological practice in Great Britain. Br Heart J 1992;67:273–7.PubMedCrossRef Underwood SR, Gibson C, Tweddel A, et al. A survey of nuclear cardiological practice in Great Britain. Br Heart J 1992;67:273–7.PubMedCrossRef
6.
go back to reference Pennell DJ, Prvulovich E, Tweddel A, et al. Nuclear cardiology in the UK: British nuclear cardiology society survey 1994. Nucl Med Comm 1998;19:305–13.CrossRef Pennell DJ, Prvulovich E, Tweddel A, et al. Nuclear cardiology in the UK: British nuclear cardiology society survey 1994. Nucl Med Comm 1998;19:305–13.CrossRef
7.
go back to reference Prvulovich E, Metcalfe MJ. Nuclear cardiology in the UK: activity and practice 1997. Eur J Nucl Med 2002;29:553–8.CrossRef Prvulovich E, Metcalfe MJ. Nuclear cardiology in the UK: activity and practice 1997. Eur J Nucl Med 2002;29:553–8.CrossRef
8.
go back to reference Kelion AD, Anagnostopoulos A, Harbinson M, Underwood SR, Metcalfe M. Myocardial perfusion scintigraphy in the UK: insights from the British Nuclear Cardiology Society Survey 2000. Heart 2005;91(suppl 4):iv2–5.PubMedCrossRef Kelion AD, Anagnostopoulos A, Harbinson M, Underwood SR, Metcalfe M. Myocardial perfusion scintigraphy in the UK: insights from the British Nuclear Cardiology Society Survey 2000. Heart 2005;91(suppl 4):iv2–5.PubMedCrossRef
9.
10.
go back to reference Lindner O, Burchert W, Bengel FM, Zimmermann R, vom Dahl J, Schaefer W, et al. Myocardial perfusion scintigraphy in Germany. Results of the 2005 query and current status. Nuklearmedizin 2007;46:49–55.PubMed Lindner O, Burchert W, Bengel FM, Zimmermann R, vom Dahl J, Schaefer W, et al. Myocardial perfusion scintigraphy in Germany. Results of the 2005 query and current status. Nuklearmedizin 2007;46:49–55.PubMed
11.
go back to reference Kaminek M, Lang O, Henzlova M. Activity of nuclear cardiology in the Czech Republic between 2000 and 2005. Eur J Nucl Med Mol Imag 2007;34:959–60.CrossRef Kaminek M, Lang O, Henzlova M. Activity of nuclear cardiology in the Czech Republic between 2000 and 2005. Eur J Nucl Med Mol Imag 2007;34:959–60.CrossRef
12.
go back to reference Petersen CL, Kjaer A. Myocardial perfusion imaging in Denmark: activity from 1997 to 2001 and current practice. Eur J Nucl Med 2003;30:137–40.CrossRef Petersen CL, Kjaer A. Myocardial perfusion imaging in Denmark: activity from 1997 to 2001 and current practice. Eur J Nucl Med 2003;30:137–40.CrossRef
14.
go back to reference Martin-Comin J, Alarco R, Banzo J, Campos L, Freire J, Garcia-Solis D, et al. Practice of nuclear medicine in Spain. Eur J Nucl Med 2001;28:105–12.PubMedCrossRef Martin-Comin J, Alarco R, Banzo J, Campos L, Freire J, Garcia-Solis D, et al. Practice of nuclear medicine in Spain. Eur J Nucl Med 2001;28:105–12.PubMedCrossRef
16.
go back to reference Anagnostopoulos C, Harbinson M, Kelion A, Kundley K, Loong CY, Notghi A, et al. Procedure guidelines for radionuclide myocardial perfusion imaging. Heart 2004;90:i1–10.PubMedCrossRef Anagnostopoulos C, Harbinson M, Kelion A, Kundley K, Loong CY, Notghi A, et al. Procedure guidelines for radionuclide myocardial perfusion imaging. Heart 2004;90:i1–10.PubMedCrossRef
17.
go back to reference Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax JJ, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005;32:855–97.PubMedCrossRef Hesse B, Tägil K, Cuocolo A, Anagnostopoulos C, Bardiés M, Bax JJ, et al. EANM/ESC procedural guidelines for myocardial perfusion imaging in nuclear cardiology. Eur J Nucl Med Mol Imaging 2005;32:855–97.PubMedCrossRef
18.
go back to reference DePuey EG, Corbett JR, Friedman JD, Goldstein RA, Henzlova MJ, Hansen CL, et al. Imaging guidelines for nuclear cardiology procedures. J Nucl Cardiol 2006;13:e21–171.CrossRef DePuey EG, Corbett JR, Friedman JD, Goldstein RA, Henzlova MJ, Hansen CL, et al. Imaging guidelines for nuclear cardiology procedures. J Nucl Cardiol 2006;13:e21–171.CrossRef
19.
go back to reference Prvulovich EM, Jarritt PH, Vivian GC, Clarke SE, Pennell DJ, Underwood SR. Quality assurance in myocardial perfusion tomography: a collaborative BNCS/BNMS audit programme. Nucl Med Commun 1998;19:831–8.PubMedCrossRef Prvulovich EM, Jarritt PH, Vivian GC, Clarke SE, Pennell DJ, Underwood SR. Quality assurance in myocardial perfusion tomography: a collaborative BNCS/BNMS audit programme. Nucl Med Commun 1998;19:831–8.PubMedCrossRef
20.
go back to reference Underwood SR, Godman B, Salyani S, Ogle J, Ell PJ. Economics of myocardial perfusion imaging in Europe: the EMPIRE study. Eur J Nucl Med 1999;20:157–66. Underwood SR, Godman B, Salyani S, Ogle J, Ell PJ. Economics of myocardial perfusion imaging in Europe: the EMPIRE study. Eur J Nucl Med 1999;20:157–66.
21.
go back to reference Heller GV, Links J, Bateman TM, Ziffer JA, Ficaro E, Cohen MC, et al. American society of nuclear cardiology and society of nuclear medicine joint position statement: attenuation correction of myocardial perfusion SPECT scintigraphy. J Nucl Cardiol 2004;11:229–30.PubMedCrossRef Heller GV, Links J, Bateman TM, Ziffer JA, Ficaro E, Cohen MC, et al. American society of nuclear cardiology and society of nuclear medicine joint position statement: attenuation correction of myocardial perfusion SPECT scintigraphy. J Nucl Cardiol 2004;11:229–30.PubMedCrossRef
Metadata
Title
Myocardial perfusion scintigraphy in Europe 2005
A survey of the European Council on Nuclear Cardiology
Authors
S. Richard Underwood
Susanna Wiener
Publication date
01-02-2009
Publisher
Springer-Verlag
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 2/2009
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-008-0942-7

Other articles of this Issue 2/2009

European Journal of Nuclear Medicine and Molecular Imaging 2/2009 Go to the issue